"Good" bacteria such as L. paracasei can help break down food, absorb nutrients, and fight off "bad" organisms that might cause diseases. Specific strains of L. paracasei are commonly added to fermented foods like yogurt and are also found in probiotic supplements.
People use L. paracasei for hay fever, eczema, and the common cold. It is also used for asthma, diarrhea, high cholesterol, and many other conditions, but there is no good scientific evidence to support these other uses. There is also no good evidence to support using L. paracasei for COVID-19.
Don't confuse L. paracasei with other probiotics, or with fermented food products such as fermented milk, kefir, or yogurt. These are not the same. Also note that L. paracasei used to be classified under the Lactobacillus genus. But Lactobacillus was split up into 25 different genera in April 2020. Some product labels might still list this species as Lactobacillus paracasei rather than its new name, Lacticaseibacillus paracasei.
Uses & Effectiveness
Possibly Effective for
- Hay fever. Taking L. paracasei by mouth seems to reduce hay fever symptoms in both adults and children.
- Eczema (atopic dermatitis). Taking L. paracasei by mouth, alone or with other probiotics, seems to help treat eczema in children. It also seems to help treat and prevent eczema in infants.
- Common cold. Taking L. paracasei by mouth with another probiotic called Lactiplantibacillus plantarum seems to help prevent the common cold. It's not clear if taking L. paracasei alone helps.
Special Precautions and Warnings
Pregnancy and breast-feeding: L. paracasei is possibly safe when taken by mouth appropriately while pregnant and breast-feeding. It's been used safely together with Bifidobacterium longum, starting 2 months before delivery and continuing until 2 months after delivery.
Children: L. paracasei is likely safe for children when taken by mouth appropriately. It's been used safely alone and together with other probiotics for up to 3 months in children of varying ages.
Digestive surgery: People having digestive surgery or a colonoscopy might be more likely to develop L. paracasei infections. If you are planning to have one of these procedures, talk with your healthcare provider before taking L. paracasei.
Weakened immune system: L. paracasei has caused blood infections in a small number of people with weakened immune systems. If you have a weakened immune system, talk with your healthcare provider before taking L. paracasei.
Damaged heart valves: L. paracasei can cause an infection in the inner lining of the heart chambers and heart valve. This is extremely rare, but people with damaged heart valves should stop taking probiotics before dental procedures or surgical procedures.
We currently have no information for LACTICASEIBACILLUS PARACASEI overview.
In adults, L. paracasei has most often been taken by mouth, alone or together with other probiotics, in doses of up to 2 billion colony-forming units (CFUs) daily for up to 5 weeks. Speak with a healthcare provider to find out what dose might be best for a specific condition.
CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.
This copyrighted material is provided by Natural Medicines Comprehensive Database Consumer Version. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
© Therapeutic Research Faculty 2020.